Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mixed Dyslipidaemia”

149 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 149 results

Not applicableStudy completedNCT05087823
What this trial is testing

The Mixed Meal Challenge Study

Who this might be right for
Cardiovascular DiseasesHyperlipidemias
Emory University 11
Large-scale testing (Phase 3)Not Yet RecruitingNCT07421284
What this trial is testing

Evaluate the Safety, Efficacy of SYH2053 in Chinese Participants With Non-familial Hypercholesterolemia and Mixed Hyperlipidemia on a Background of Lipid-lowering Therapy

Who this might be right for
Non-familial Hypercholesterolemia and Mixed Hyperlipidemia
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. 900
Not applicableStudy completedNCT05118230
What this trial is testing

Study to Assess the Real World Effectiveness of Inclisiran in Chinese Adult Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia

Who this might be right for
Primary HypercholesterolemiaMixed Dyslipidemia
Novartis Pharmaceuticals 61
Early research (Phase 1)Study completedNCT07319559
What this trial is testing

Clinical Trial to Evaluate the Safety, Pharmacokinetic Characteristics of DW5124 and DW5124-R, and the Effect of Food on DW5124 in Healthy Adult Volunteers

Who this might be right for
Mixed Dyslipidemia
Daewon Pharmaceutical Co., Ltd. 55
Testing effectiveness (Phase 2)Study completedNCT04516291
What this trial is testing

A Dose-Ranging Study With Vupanorsen (TRANSLATE-TIMI 70)

Who this might be right for
DyslipidemiasHyperlipidemiasHyperlipoproteinemias
Pfizer 286
Large-scale testing (Phase 3)Study completedNCT04849000
What this trial is testing

Study of SHR-1209 in the Treatment of Hypercholesterolemia and Hyperlipidemia Ⅲ Stage

Who this might be right for
Primary HypercholesterolemiaMixed Hyperlipemia
Jiangsu HengRui Medicine Co., Ltd. 709
Testing effectiveness (Phase 2)Looking for participantsNCT07223658
What this trial is testing

Study of ARO-DIMERPA in Adult Participants With Mixed Hyperlipidemia

Who this might be right for
Hyperlipidemia; Mixed
Arrowhead Pharmaceuticals 78
Early research (Phase 1)Study completedNCT06923956
What this trial is testing

Single Dose Oral Bioequivalence Study of Bempedoic Acid 180 mg Film Coated Tablet and Nilemdo® (Bempedoic Acid) 180 mg Film-coated Tablets in Healthy Adult Human Subjects Under Fasting Conditions.

Who this might be right for
HypercholesterolaemiaMixed DyslipidaemiaCardiovascular Diseases
Humanis Saglık Anonim Sirketi 14
Large-scale testing (Phase 3)Study completedNCT00362934
What this trial is testing

Comparison of the Combination of Fenofibrate and Simvastatin Versus Atorvastatin

Who this might be right for
Hyperlipidemia
Solvay Pharmaceuticals 516
Large-scale testing (Phase 3)Study completedNCT05255458
What this trial is testing

Evaluate the Long-term Efficacy and Safety of AK102 in Patients With Hyperlipidemia

Who this might be right for
Hyperlipidemia
Akeso 122
Large-scale testing (Phase 3)Study completedNCT00300469
What this trial is testing

Evaluate Safety and Efficacy of ABT-335 in Combination With Atorvastatin in Subjects With Multiple Abnormal Lipid Levels in the Blood

Who this might be right for
Mixed DyslipidemiaCoronary Heart DiseaseDyslipidemia
Abbott 613
Large-scale testing (Phase 3)UnknownNCT01956201
What this trial is testing

Efficacy and Safety of Fenofibrate Added on to Atorvastatin Compared With Atorvastatin

Who this might be right for
Mixed Hyperlipidemia
Chong Kun Dang Pharmaceutical 476
Not applicableStudy completedNCT00309712
What this trial is testing

Diabetes and Combined Lipid Therapy Regimen (DIACOR) Study

Who this might be right for
Type II Diabetes MellitusMixed Dyslipidemia
Intermountain Health Care, Inc. 300
Large-scale testing (Phase 3)Ended earlyNCT01335997
What this trial is testing

Efficacy and Safety of Extended-Release Niacin/ Laropiprant/Simvastatin Tablets in Participants With Hypercholesterolemia or Mixed Dyslipidemia (MK-0524B-143)

Who this might be right for
Primary HypercholesterolemiaMixed Dyslipidemia
Merck Sharp & Dohme LLC 1,139
Testing effectiveness (Phase 2)Study completedNCT04832971
What this trial is testing

Study of ARO-ANG3 in Adults With Mixed Dyslipidemia

Who this might be right for
Mixed Dyslipidemia
Arrowhead Pharmaceuticals 204
Post-approval studies (Phase 4)Study completedNCT00678743
What this trial is testing

An Open-label Extension to Assess the Continued Efficacy of Omacor Plus Simvastatin

Who this might be right for
Dyslipidemias
Provident Clinical Research 17
Large-scale testing (Phase 3)Looking for participantsNCT05400317
What this trial is testing

Evaluate the Efficacy and Safety of AD-218

Who this might be right for
Mixed Dyslipidemia
Addpharma Inc. 520
Large-scale testing (Phase 3)Study completedNCT01879319
What this trial is testing

Study to Assess in Home Use of Evolocumab (AMG 145) Administration Using Either an Automated Mini-doser or a Prefilled Autoinjector/Pen

Who this might be right for
Primary HypercholesterolemiaMixed Dyslipidemia
Amgen 164
Large-scale testing (Phase 3)Study completedNCT00093899
What this trial is testing

Evaluate an Investigational Drug in Patients With Mixed Hyperlipidemia (0653A-071)(COMPLETED)

Who this might be right for
HyperlipidemiaHypercholesterolemiaHypertriglyceridemia
Organon and Co 611
Early research (Phase 1)Study completedNCT01632358
What this trial is testing

Safety and Pharmacokinetis of TAP311 in Dyslipidemic Patients

Who this might be right for
Dyslipidaemia
Novartis Pharmaceuticals 279
Load More Results